Vitamin D Supplementation Prevents Elderly Pneumonia

Status Completed

Clinical Trial Summary

Pneumonia is the fourth leading cause of death and frequently occurs in institutionalized elderly people in Japan. Recently, several clinical and experimental studies have reported the importance of vitamin D in the regulation of immune functions and its deficiency is associated with susceptibility to some infections. In the present study, the investigators hypothesize that deficiency of serum vitamin D is associated with development of pneumonia, and supplementation of vitamin D may lower the incidence of pneumonia and prolong survival in institutionalized elderly subjects.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00877422
Study type	Interventional
Source	Tohoku University
Contact
Status	Completed
Phase	N/A
Start date	August 2008

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01570192` - Clinical Trials to Reduce the Risk of Antimicrobial Resistance	Phase 2
Recruiting	`NCT04952337` - Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
Completed	`NCT02493764` - Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)	Phase 3
Completed	`NCT02531438` - Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)	Phase 3
Completed	`NCT00079885` - Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia	Phase 3
Recruiting	`NCT05629741` - A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101	Phase 1
Completed	`NCT05417997` - Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients	Phase 3
Withdrawn	`NCT00645619` - Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Completed	`NCT00509106` - Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia	Phase 3
Completed	`NCT00080496` - Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia	Phase 3
Completed	`NCT03158727` - Cx611-0204 SEPCELL Study	Phase 1/Phase 2
Completed	`NCT00621504` - Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia	Phase 3
Completed	`NCT00124020` - Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus	Phase 3
Completed	`NCT00081575` - Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia	Phase 3
Completed	`NCT00451386` - Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)	Phase 2
Recruiting	`NCT03752320` - Multiplex Polymerase Chain Reaction in Postoperative Pneumonia After Thoracic Surgery
Active, not recruiting	`NCT04779242` - Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia	Phase 3
Completed	`NCT00763620` - Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction Catheter	N/A
Completed	`NCT00107952` - Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus	Phase 3
Terminated	`NCT03862040` - Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia	Phase 1